Data as of Apr 17
| -0.0053 / -1.63%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +368.75% increase from the last price of 0.32.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.